INTRINSIC PROBES OF SMOOTH MUSCLE MYOSIN DYNAMICS
平滑肌肌球蛋白动力学的内在探针
基本信息
- 批准号:7172332
- 负责人:
- 金额:$ 35.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:ATP HydrolysisATP phosphohydrolaseATP-G-actinActinsActive SitesAddressAffinityBindingBiochemicalBiological ClocksCardiovascular DiseasesCatalytic DomainChemicalsCleaved cellCoupledCytokinesisDNA Sequence RearrangementDiseaseEngineeringEventF-ActinFamilial Hypertrophic CardiomyopathyFluorescenceFluorescent ProbesGoalsHydrolysisInheritedKineticsLeadLinkLocationMediatingMolecularMolecular MotorsMonitorMotionMotorMovementMuscleMuscle ContractionMutationMyosin ATPaseNucleotidesOrganellesPoint MutationPositioning AttributeProcessProductionProtein IsoformsProteinsRelative (related person)ReportingResearchResearch PersonnelSeriesSignal TransductionSiteSkeletal systemSmooth Muscle MyosinsSolutionsStagingStructureTestingThinkingTimeTryptophanUpper armactin 2cell motilitydesigndesireinorganic phosphateinterestprogramsresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): The ultimate goal of this proposal is to examine conformational changes at specific locations within smooth muscle myosin using intrinsic tryptophan fluorescence. Smooth muscle myosin constructs will be genetically engineered to contain either a single tryptophan or a pair of tryptophans at the desired site of interest, which will provide a unique intrinsic fluorescence signal reporting local conformational and structural changes in response to nucleotide binding, ATP hydrolysis, actin-binding, and lever arm movement. These experiments are complementary to the ongoing structural studies in the field, allowing us to explicitly test predictions about domain movements and structural rearrangements during critical steps in the contractile cycle of smooth muscle myosin. Thus we will be able to correlate structural changes in myosin with functional consequences, which relates directly to certain cardiovascular disease. For example, FHC (familial hypertrophic cardiomyopathy) is an inherited, often lethal disease caused by point mutations at key structures within myosin critical to its proper functioning as a molecular motor. We will be examining structural changes in myosin in regions of the molecule directly impacted by mutations that underlie FHC. This will lead to a better understanding of the disease, and thus to better treatment options as well. Therefore, this proposal offers a unique opportunity to critically test fundamental questions about the molecular mechanism of muscle contraction that have not been previously accessible by other spectroscopic probe studies, and the results will have important implications for serious disease states such as FHC.
描述(由申请人提供):该提案的最终目标是使用内在色氨酸荧光检查平滑肌肌球蛋白内特定位置的构象变化。平滑肌肌球蛋白构建体将经过基因工程改造,在所需的感兴趣位点包含单个色氨酸或一对色氨酸,这将提供独特的内在荧光信号,报告响应于核苷酸结合、ATP 水解、肌动蛋白的局部构象和结构变化。 - 绑定和杠杆臂运动。这些实验是对该领域正在进行的结构研究的补充,使我们能够明确测试有关平滑肌肌球蛋白收缩周期关键步骤中域运动和结构重排的预测。因此,我们将能够将肌球蛋白的结构变化与功能后果联系起来,这与某些心血管疾病直接相关。例如,FHC(家族性肥厚型心肌病)是一种遗传性的、通常致命的疾病,由肌球蛋白内关键结构的点突变引起,这对于肌球蛋白作为分子马达的正常功能至关重要。我们将检查直接受 FHC 突变影响的分子区域中肌球蛋白的结构变化。这将有助于更好地了解这种疾病,从而提供更好的治疗选择。因此,该提案提供了一个独特的机会来批判性地测试有关肌肉收缩分子机制的基本问题,而这些问题以前是其他光谱探针研究无法获得的,并且结果将对 FHC 等严重疾病状态产生重要影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER L. BERGER其他文献
CHRISTOPHER L. BERGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER L. BERGER', 18)}}的其他基金
INTRINSIC PROBES OF SMOOTH MUSCLE MYOSIN DYMAMICS
平滑肌肌球蛋白动力学的内在探针
- 批准号:
6351592 - 财政年份:2000
- 资助金额:
$ 35.84万 - 项目类别:
相似海外基金
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
首创肌球蛋白 10 抑制剂作为胶质母细胞瘤新靶标的药物发现
- 批准号:
10355649 - 财政年份:2021
- 资助金额:
$ 35.84万 - 项目类别:
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
首创肌球蛋白 10 抑制剂作为胶质母细胞瘤新靶标的药物发现
- 批准号:
10595848 - 财政年份:2021
- 资助金额:
$ 35.84万 - 项目类别:
Role and Mechanism of ATP Hydrolysis in Actin
ATP 水解在肌动蛋白中的作用和机制
- 批准号:
8494411 - 财政年份:2011
- 资助金额:
$ 35.84万 - 项目类别:
Role and Mechanism of ATP Hydrolysis in Actin
ATP 水解在肌动蛋白中的作用和机制
- 批准号:
8061481 - 财政年份:2011
- 资助金额:
$ 35.84万 - 项目类别: